3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
38
Breast Neoplasms
20
Pancreatic Neoplasms
19
Rectal Neoplasms
18
Colonic Neoplasms
17
Gastrointestinal Neoplasms
16
Prostatic Neoplasms
12
Esophageal Neoplasms
12
Stomach Neoplasms
11
Lung Neoplasms
11
Colorectal Neoplasms, Hereditary Nonpolyposis
10
Endometrial Neoplasms
9
Anus Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Motor Activity
4
cyclopia sequence
3
Sarcoma
3
Ovarian Neoplasms
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Disease
3
Carcinoma, Renal Cell
3
Carcinoma, Hepatocellular
3
Appendiceal Neoplasms
3
Vulvar Neoplasms
2
Vomiting
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Interventions
Cyclophosphamide
4
pembrolizumab
3
Nivolumab
3
regorafenib
2
fludarabine
2
SS1(dsFv)PE38
2
Ipilimumab
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Decitabine
2
Cisplatin
2
tislelizumab
1
sodium thiosulfate
1
sargramostim
1
entinostat
1
durvalumab
1
cemiplimab
1
bemcentinib
1
avelumab
1
atezolizumab
1
alvocidib
1
alanosine
1
X-Rays
1
Tetrahydrouridine
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Surveys and Questionnaires
×
Gastrointestinal
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled